Seeing Is Believing
Currently out of the existing stock ratings of Graham Parry, 3 are a HOLD (42.86%), 1 are a SELL (14.29%), 3 are a BUY (42.86%).
Analyst Graham Parry works at BAML
Graham Parry’s has documented 12 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 12-Sep-2023.
Analyst best performing recommendations are on GSK (GLAXOSMITHKLINE PLC ADR).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
44
$0.5 (1.15%)
18.72
3 months 12 days ago
0/14 (0%)
$5.1 (13.11%)
Buy
48
$4.5 (10.34%)
39
4 months 2 days ago
1/3 (33.33%)
$9.46 (24.55%)
265
Hold
19.52
$-23.98 (-55.13%)
18.9
8 months 21 days ago
0/3 (0%)
$-14.87 (-43.24%)
Hold
19.58
$-22.45 (-53.41%)
19.96
1 years 14 days ago
0/2 (0%)
$-16.05 (-45.05%)
Buy
21.66
1 years 1 months 18 days ago
0/13 (0%)
$-19.7 (-47.63%)
What Year was the first public recommendation made by Graham Parry?